EUVIMEDEUVIMED entdecken
Open Access

Disease-associated mosaic variation in clinical exome sequencing: a two-year pediatric tertiary care experience

Cecelia R Miller, Kristy Lee, Ruthann B Pfau, Shalini C Reshmi, Donald J Corsmeier, Sayaka Hashimoto, Ashita Dave-Wala, Vijayakumar Jayaraman, Daniel Koboldt, Theodora Matthews, Danielle Mouhlas, Maggie Stein und 8 weitere

Molecular Case Studies · 2020-06 · 6 (3) · a005231

DOI: 10.1101/mcs.a005231 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Case Studies, online erschienen am 05.05.2020. Verfasst von Cecelia R Miller und 19 weiteren Autor:innen. Beteiligte Einrichtung: The Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, Ohio 43205, USA. Hauptthemen laut MEDLINE: Genetic Association Studies, Genetic Predisposition to Disease, Genetic Variation, Mosaicism. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Exome sequencing (ES) has become an important tool in pediatric genomic medicine, improving identification of disease-associated variation due to assay breadth. Depth is also afforded by ES, enabling detection of lower-frequency mosaic variation compared to Sanger sequencing in the studied tissue, thus enhancing diagnostic yield. Within a pediatric tertiary-care hospital, we report two years of clinical ES data from probands evaluated for genetic disease to assess diagnostic yield, characteristics of causal variants, and prevalence of mosaicism among disease-causing variants. Exome-derived, phenotype-driven variant data from 357 probands was analyzed concurrent with parental ES data, when available. Blood was the source of nucleic acid. Sequence read alignments were manually reviewed for all assessed variants. Sanger sequencing was used for suspected de novo or mosaic variation. Clinical provider notes were reviewed to determine concordance between laboratory-reported data and the ordering provider's interpretation of variant-associated disease causality. Laboratory-derived diagnostic yield and provider-substantiated diagnoses had 91.4% concordance. The cohort returned 117 provider-substantiated diagnoses among 115 probands for a diagnostic yield of 32.2%. De novo variants represented 64.9% of disease-associated variation within trio analyses. Among the 115 probands, five harbored disease-associated somatic mosaic variation. Two additional probands were observed to inherit a disease-associated variant from an unaffected mosaic parent. Among inheritance patterns, de novo variation was the most frequent disease etiology. Somatic mosaicism is increasingly recognized as a significant contributor to genetic disease, particularly with increased sequence depth attainable from ES. This report highlights the potential and importance of detecting mosaicism in ES.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic Association StudiesGenetic Predisposition to DiseaseGenetic VariationMosaicismAdolescentAdultChildChild, PreschoolFemaleGenomicsHumansInfantInfant, NewbornMaleMiddle AgedMutationPediatricsPhenotypeTertiary Health CareExome SequencingYoung Adult

Stichwörter der Autor:innen

autismdelayed gross motor developmentfailure to thrive in infancymicrocephalyprofound global developmental delaysevere muscular hypotoniashort stature

Autor:innen und Institutionen

  • The Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, Ohio 43205, USA.
  • Department of Pathology.
  • Department of Pediatrics, The Ohio State University, Columbus, Ohio 43210, USA.

ORCID-Profile: Peter White

Zitieren

APA

Miller, C. R., Lee, K., Pfau, R. B., Reshmi, S. C., Corsmeier, D. J., Hashimoto, S., Dave-Wala, A., Jayaraman, V., Koboldt, D., Matthews, T., Mouhlas, D., Stein, M., McKinney, A., Grossman, T., Kelly, B. J., White, P., Magrini, V., Wilson, R. K., Mardis, E. R., & Cottrell, C. E. (2020). Disease-associated mosaic variation in clinical exome sequencing: a two-year pediatric tertiary care experience. Molecular Case Studies, 6(3), a005231. https://doi.org/10.1101/mcs.a005231

Vancouver

Miller CR, Lee K, Pfau RB, Reshmi SC, Corsmeier DJ, Hashimoto S, et al. Disease-associated mosaic variation in clinical exome sequencing: a two-year pediatric tertiary care experience. Molecular Case Studies. 2020;6(3):a005231. doi:10.1101/mcs.a005231

BibTeX
@article{Miller2020,
  author = {Miller, Cecelia R and Lee, Kristy and Pfau, Ruthann B and Reshmi, Shalini C and Corsmeier, Donald J and Hashimoto, Sayaka and Dave-Wala, Ashita and Jayaraman, Vijayakumar and Koboldt, Daniel and Matthews, Theodora and Mouhlas, Danielle and Stein, Maggie and McKinney, Aimee and Grossman, Tom and Kelly, Benjamin J and White, Peter and Magrini, Vincent and Wilson, Richard K and Mardis, Elaine R and Cottrell, Catherine E},
  title = {Disease-associated mosaic variation in clinical exome sequencing: a two-year pediatric tertiary care experience},
  journal = {Molecular Case Studies},
  year = {2020},
  volume = {6},
  number = {3},
  pages = {a005231},
  doi = {10.1101/mcs.a005231}
}
Kostenlos starten →